BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7763744)

  • 1. Interferon-gamma-induced differentiation of human neuroblastoma cells increases cellular uptake and halflife of metaiodobenzylguanidine.
    Montaldo PG; Carbone R; Cornaglia Ferraris P; Ponzoni M
    Cytotechnology; 1993; 11 Suppl 1():S140-3. PubMed ID: 7763744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. gamma-Interferon increases metaiodobenzylguanidine incorporation and retention in human neuroblastoma cells.
    Montaldo PG; Carbone R; Ponzoni M; Cornaglia-Ferraris P
    Cancer Res; 1992 Sep; 52(18):4960-4. PubMed ID: 1325288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-γ-induced differentiation of human neuroblastoma cells increases cellular uptake and halflife of metaiodobenzylguanidine.
    Montaldo PG; Carbone R; Cornaglia Ferraris P; Ponzoni M
    Cytotechnology; 1993 Jan; 11(Suppl 1):S140-3. PubMed ID: 22358680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of metaiodobenzylguanidine uptake and intracellular half-life during differentiation of human neuroblastoma cells.
    Montaldo PG; Raffaghello L; Guarnaccia F; Pistoia V; Garaventa A; Ponzoni M
    Int J Cancer; 1996 Jul; 67(1):95-100. PubMed ID: 8690531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human neuroblastoma xenograft model for [131I]-metaiodobenzylguanidine (MIBG) biodistribution and targeted radiotherapy.
    Rutgers M; Gubbels AA; Hoefnagel CA; Voûte PA; Smets LA
    Prog Clin Biol Res; 1991; 366():471-8. PubMed ID: 2068162
    [No Abstract]   [Full Text] [Related]  

  • 6. No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.
    Mairs RJ; Cunningham SH; Russell J; Armour A; Owens J; McKellar K; Gaze MN
    J Nucl Med; 1995 Jun; 36(6):1088-95. PubMed ID: 7769433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology of metaiodobenzylguanidine interactions with human neuroblastoma cells.
    Iavarone A; Lasorella A; Servidei T; Riccardi R; Troncone L; Mastrangelo R
    J Nucl Biol Med (1991); 1991; 35(4):186-90. PubMed ID: 1823815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro pharmacology of metaiodobenzylguanidine uptake, storage and release in human neuroblastoma cells.
    Montaldo PG; Carbone R; Lanciotti M; Ponzoni M; Cornaglia-Ferraris P
    J Nucl Biol Med (1991); 1991; 35(4):195-8. PubMed ID: 1823817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
    Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake and storage of m-iodobenzylguanidine are frequent neuronal functions of human neuroblastoma cell lines.
    Iavarone A; Lasorella A; Servidei T; Riccardi R; Mastrangelo R
    Cancer Res; 1993 Jan; 53(2):304-9. PubMed ID: 8417824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of the uptake of 131I-radiolabelled meta-iodobenzylguanidine (mIBG) for the targeted radiotherapy of neuroblastoma.
    O'Donoghue JA; Wheldon TE; Babich JW; Moyes JS; Barrett A; Meller ST
    Br J Radiol; 1991 May; 64(761):428-34. PubMed ID: 2036567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma.
    O'Donoghue JA; Wheldon TE; Babich JW; Moyes JS; Barrett A; Meller ST
    Prog Clin Biol Res; 1991; 366():455-61. PubMed ID: 2068160
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
    Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
    Weber W; Weber J; Senekowitsch-Schmidtke R
    Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of m-iodobenzylguanidine by neuroblastoma cells results from independent uptake and storage mechanisms.
    Montaldo PG; Lanciotti M; Casalaro A; Cornaglia-Ferraris P; Ponzoni M
    Cancer Res; 1991 Aug; 51(16):4342-6. PubMed ID: 1868458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells.
    Smets LA; Loesberg C; Janssen M; Metwally EA; Huiskamp R
    Cancer Res; 1989 Jun; 49(11):2941-4. PubMed ID: 2720653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
    Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model studies on metaiodobenzylguanidine (MIBG) uptake and storage: relevance for 131I-MIBG therapy of neuroblastoma.
    Smets LA; Rutgers M
    J Nucl Biol Med (1991); 1991; 35(4):191-4. PubMed ID: 1823816
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific uptake of 125-I-metaiodobenzylguanidine in human neuroblastoma cell lines is associated with the neuroblastic cell type.
    Iavarone A; Servidei T; Riccardi R; Lasorella A; Mastrangelo R
    Prog Clin Biol Res; 1991; 366():447-54. PubMed ID: 2068158
    [No Abstract]   [Full Text] [Related]  

  • 20. SIMS microscopy imaging of the intratumor biodistribution of metaiodobenzylguanidine in the human SK-N-SH neuroblastoma cell line xenografted into nude mice.
    Clerc J; Halpern S; Fourré C; Omri F; Briançon C; Jeusset J; Fragu P
    J Nucl Med; 1993 Sep; 34(9):1565-70. PubMed ID: 8355077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.